TY - JOUR A1 - Trimpert, J. A1 - Groenke, N. A1 - Kunec, D. A1 - Eschke, K. A1 - He, Shulin A1 - McMahon, Dino Peter A1 - Osterrieder, N. T1 - A proofreading-impaired herpesvirus generates populations with quasispecies-like structure N2 - RNA virus populations are composed of highly diverse individuals that form a cloud of related sequences commonly referred to as a ‘quasispecies’1–3. This diversity arises as a consequence of low-fidelity genome replication4,5. By contrast, DNA Virus populations contain more uniform individuals with similar fitness6. Genome diversity is often correlated with increased Fitness in RNA viruses, while DNA viruses are thought to require more faithful genome replication. During DNA replication, erroneously incorporated bases are removed by a 3′-5′ exonuclease, a highly conserved enzymatic function of replicative DNA but not RNA polymerases. This proofreading process enhances replication fidelity and ensures the genome integrity of DNA organisms, including large DNA viruses7. Here, we show that a herpesvirus can tolerate impaired exonucleolytic proofreading, resulting in DNA virus populations, which, as in RNA viruses8, are composed of highly diverse genotypes of variable individual fitness. This indicates that herpesvirus mutant diversity may compensate for individual Fitness loss. Notably, in vivo infection with diverse virus populations results in a marked increase in virulence compared to genetically homogenous parental virus. While we cannot exclude that the increase in virulence is caused by selection of and/or interactions between individual genotypes, our findings are consistent with quasispecies dynamics. Our results contrast with traditional views of DNA virus replication and evolution, and indicate that a substantial increase in population diversity can lead to higher virulence. KW - Marek's virus KW - Virulence KW - Quasispecies KW - Evolution PY - 2019 DO - https://doi.org/10.1038/s41564-019-0547-x SN - 2058-5276 N1 - Corrigendum: Nature Microbiology 4 (2019) 2025 VL - 4 SP - 2175 EP - 2183 PB - Nature Publishing Group CY - London AN - OPUS4-48896 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Donskyi, Ievgen A1 - Azab, W. A1 - Cuellar-Camach, J. L. A1 - Guday, G. A1 - Lippitz, Andreas A1 - Unger, Wolfgang A1 - Osterrieder, K. A1 - Adeli, M. A1 - Haag, R. T1 - Functionalized nanographene sheets with high antiviral activity through synergistic electrostatic and hydrophobic interactions N2 - As resistance to traditional drugs emerges for treatment of Virus infections, the need for new methods for virus inhibition increases. Graphene derivatives with large surface areas have shown strong activity against different viruses. However, the inability of current synthetic protocols to accurately manipulate the structure of graphene sheets in order to control their antiviral activity remains a major challenge. In this work, a series of graphene derivatives with defined polyglycerol sulfate and fatty amine functionalities have been synthesized and their interactions with herpes simplex Virus type 1 (HSV-1) are investigated. While electrostatic interactions between polyglycerol sulfate and virus particles trigger the binding of graphene to virus, alkyl chains induce a high antiviral activity by secondary hydrophobic interactions. Among graphene sheets with a broad range of alkyl chains, (C3–C18), the C12-functionalized sheets showed the highest antiviral activity, indicating the optimum synergistic effect between electrostatic and hydrophobic interactions, but this derivative was toxic against the Vero cell line. In contrast, sheets functionalized with C6- and C9-alkyl chains showed low toxicity against Vero cells and a synergistic Inhibition of HSV-1. This study shows that antiviral agents against HSV-1 can be obtained by controlled and stepwise functionalization of graphene sheets and may be developed into antiviral agents for future biomedical applications. KW - Functionalized nanographene KW - X-ray Photoelectron Spectroscopy (XPS) KW - NEXAFS KW - Antiviral activity PY - 2019 DO - https://doi.org/10.1039/c9nr05273a SN - 2040-3364 VL - 11 IS - 34 SP - 15804 EP - 15809 PB - The Royal Society of Chemistry AN - OPUS4-48807 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -